These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8018382)

  • 1. Tenth anniversary perspectives on AIDS. FIV as a model for AIDS vaccination.
    Johnson CM; Torres BA; Koyama H; Yamamoto JK
    AIDS Res Hum Retroviruses; 1994 Mar; 10(3):225-8. PubMed ID: 8018382
    [No Abstract]   [Full Text] [Related]  

  • 2. Feline immunodeficiency virus as a model for AIDS vaccination.
    Jarrett O; Yamamoto JK; Neil JC
    AIDS; 1990; 4 Suppl 1():S163-5. PubMed ID: 1967108
    [No Abstract]   [Full Text] [Related]  

  • 3. The development of a vaccine against feline immunodeficiency virus.
    Hosie MJ
    Br Vet J; 1994; 150(1):25-39. PubMed ID: 8025833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feline immunodeficiency virus infection--a model for HIV and AIDS?
    Bennett M; Hart CA
    J Med Microbiol; 1995 Apr; 42(4):233-6. PubMed ID: 7707329
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaccination against the feline immunodeficiency virus: the road not taken.
    Lecollinet S; Richardson J
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):167-90. PubMed ID: 17706778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FIV and HIV vaccines--problems and prospects.
    Harbour DA
    Br Vet J; 1994; 150(1):7-8. PubMed ID: 8025838
    [No Abstract]   [Full Text] [Related]  

  • 7. Feline immunodeficiency virus pathogenesis and development of a dual-subtype feline-immunodeficiency-virus vaccine.
    Yamamoto JK; Pu R; Sato E; Hohdatsu T
    AIDS; 2007 Mar; 21(5):547-63. PubMed ID: 17314517
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanism(s) of FIV vaccine protection.
    Pu R; Tellier MC; Yamamoto JK
    Leukemia; 1997 Apr; 11 Suppl 3():98-101. PubMed ID: 9209311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small animal model of AIDS and the feline immunodeficiency virus.
    Bendinelli M; Pistello M; Matteucci D; Lombardi S; Baldinotti F; Bandecchi P; Ghilarducci R; Ceccherini-Nelli L; Garzelli C; Poli A
    Adv Exp Med Biol; 1993; 335():189-202. PubMed ID: 8237595
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental vaccine protection against feline immunodeficiency virus.
    Yamamoto JK; Okuda T; Ackley CD; Louie H; Pembroke E; Zochlinski H; Munn RJ; Gardner MB
    AIDS Res Hum Retroviruses; 1991 Nov; 7(11):911-22. PubMed ID: 1662057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIV and FIV vaccine studies at UC Davis: 1991 update.
    Gardner M; Yamamoto J; Marthas M; Miller C; Jennings M; Rosenthal A; Luciw P; Planelles V; Yilma T; Giavedoni L
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1495-8. PubMed ID: 1334682
    [No Abstract]   [Full Text] [Related]  

  • 12. Lessons from the cat: development of vaccines against lentiviruses.
    Dunham SP
    Vet Immunol Immunopathol; 2006 Jul; 112(1-2):67-77. PubMed ID: 16678276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gag-specific immune enhancement of lentiviral infection after vaccination with an adenoviral vector in an animal model of AIDS.
    Klonjkowski B; Klein D; Galea S; Gavard F; Monteil M; Duarte L; Fournier A; Sayon S; Górna K; Ertl R; Cordonnier N; Sonigo P; Eloit M; Richardson J
    Vaccine; 2009 Feb; 27(6):928-39. PubMed ID: 19070641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vaccination against feline retrovirus infections].
    Horzinek MC
    Tierarztl Prax; 1996 Apr; 24(2):197-202. PubMed ID: 8650690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developments in preclinical AIDS vaccine efficacy models.
    Bogers WM; Cheng-Mayer C; Montelaro RC
    AIDS; 2000; 14 Suppl 3():S141-51. PubMed ID: 11086857
    [No Abstract]   [Full Text] [Related]  

  • 16. Deluge of questions prompts AAFP to develop FIV vaccine brief. American Association of Feline Practitioners.
    Kahler SC;
    J Am Vet Med Assoc; 2002 Nov; 221(9):1231-4. PubMed ID: 12418682
    [No Abstract]   [Full Text] [Related]  

  • 17. AIDS vaccination studies with an ex vivo feline immunodeficiency virus model: analysis of the accessory ORF-A protein and DNA as protective immunogens.
    Pistello M; Bonci F; Flynn JN; Mazzetti P; Isola P; Zabogli E; Camerini V; Matteucci D; Freer G; Pelosi P; Bendinelli M
    J Virol; 2006 Sep; 80(18):8856-68. PubMed ID: 16940498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-subtype FIV vaccine (Fel-O-Vax FIV) protection against a heterologous subtype B FIV isolate.
    Pu R; Coleman J; Coisman J; Sato E; Tanabe T; Arai M; Yamamoto JK
    J Feline Med Surg; 2005 Feb; 7(1):65-70. PubMed ID: 15686976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward vaccination against feline leukemia virus and feline immunodeficiency virus infections.
    Osterhaus AD; Weijer K; Siebelink KH; Rimmelzwaan GF; Bosch ML
    J Am Vet Med Assoc; 1991 Nov; 199(10):1443-6. PubMed ID: 1666100
    [No Abstract]   [Full Text] [Related]  

  • 20. Feline immunodeficiency virus model to study human immunodeficiency virus/acquired immune deficiency syndrome conditions.
    Levine DF; Gutmann JL; Witherspoon DE; Nunn ME; Wiggs RB
    J Endod; 2001 Jul; 27(7):467-9. PubMed ID: 11503998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.